TY  - GEN
AU  - Wang,Meng
AU  - Xu,Huzi
AU  - Chong Lee Shin,Octavia Li-Sien
AU  - Li,Li
AU  - Gao,Hui
AU  - Zhao,Zhi
AU  - Zhu,Fan
AU  - Zhu,Han
AU  - Liang,Wangqun
AU  - Qian,Kun
AU  - Zhang,Chunxiu
AU  - Zeng,Rui
AU  - Zhou,Hanjing
AU  - Yao,Ying
TI  - Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways
SN  - 1479-5876
PY  - 2020///0410
KW  - Animals
KW  - Apoptosis
KW  - drug effects
KW  - Diet, Protein-Restricted
KW  - Dietary Supplements
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Inflammation
KW  - pathology
KW  - Keto Acids
KW  - pharmacology
KW  - MAP Kinase Signaling System
KW  - Male
KW  - Mice, Inbred C57BL
KW  - Middle Aged
KW  - NF-kappa B
KW  - metabolism
KW  - Probability
KW  - Renal Insufficiency, Chronic
KW  - drug therapy
KW  - Reperfusion Injury
KW  - complications
KW  - Survival Analysis
KW  - Tablets
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/s12967-019-1856-9
ER  -